The Ethical Dilemma Associated With Vaccinations - amazonia.fiocruz.br

The Ethical Dilemma Associated With Vaccinations Video

Ethical Dilemmas Posed by COVID-19

The Ethical Dilemma Associated With Vaccinations - that

These controls allow EU member states to deny authorisation of vaccine exports if the company producing the vaccine has not honoured its contracts with the EU. While AstraZeneca claim that supply issues are a result of logistical problems, including production glitches and the late signing of contracts, the EU have argued that some of the AstraZeneca vaccine being produced in England, that was intended for EU citizens, has instead been supplied to the UK. Vaccine nationalism is at the root of these disputes, and it raises a number of ethical and scientific questions. Vaccine nationalism refers to the belief that each country is responsible for the inoculation of its own population only. Each government has a duty to vaccinate the people of its country, and has no responsibility towards the vaccination of the rest of the global population. The issue with this is that some countries are richer than others, and since the pharmaceutical industry is largely privatised, vaccines are owned by companies who charge for their production. All countries have to buy the vaccine from these companies, and are unable to produce it in their own laboratories. This has naturally led to richer countries being able to buy up vast quantities of vaccines — often more than they actually need — while poorer countries are left behind. The UK has acquired over million doses of vaccines both approved and still in trial stages , for its population of 67 million. The Ethical Dilemma Associated With Vaccinations

Despite the existence of established treatments for hepatitis C virus HCVmore effective means of preventing infection, such as a vaccine, are arguably needed to help reduce substantial global morbidity and mortality. Given the expected challenges of developing such a vaccine among those at heightened risk of infection, controlled human infection studies seem to be a promising potential approach to HCV vaccine development, but they raise substantial ethical and practical concerns.

In this article, we describe some of the challenges related to the possibility of using controlled human infection studies to accelerate HCV vaccine development. The related ethical and practical concerns require further deliberation before such studies are planned and implemented.

All rights reserved. For permissions, e-mail: journals. National Library of Medicine. N2 - Despite the existence of established treatments for hepatitis C virus HCVmore effective means of preventing infection, such as a vaccine, are arguably needed to help reduce substantial global morbidity and mortality.

Newsletter

AB - Despite the existence of established treatments for hepatitis C virus HCVmore effective means of preventing infection, such as a vaccine, are arguably needed to help reduce substantial global morbidity and mortality. School of Medicine Academic Centers.

Overview Fingerprint. Abstract Despite the existence of established treatments for hepatitis C virus HCVmore effective means of preventing infection, such as a vaccine, are arguably needed to help reduce substantial global morbidity and mortality.

Featured video

Keywords challenge studies controlled human infection studies ethics hepatitis C virus vaccines. Access to Document Link to publication in Scopus. Link to the citations in Scopus. Clinical infectious diseases : an official publication of the Infectious Diseases Here of America71 11 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.]